ArticleCureus2026
Recurrent Pituitary Adenoma Causing Cushing's Disease in a Patient With Lynch Syndrome.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Genetic testing in pituitary adenomas: a Pituitary Society International Consensus Statement.Nature reviews. Endocrinology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cushing's disease (CD) is a severe endocrine disorder caused by an adrenocorticotropic hormone (ACTH)-secreting pituitary microadenoma. The diagnosis of CD remains one of the most challenging in endocrinology due to a wide array of symptoms caused by the extensive distribution of glucocorticoid receptors. Transsphenoidal surgery (TSS) is the first-line treatment, but recurrence following TSS is not uncommon. Repeat TSS and pituitary radiotherapy are among the second-line treatments of CD. Separately, Lynch syndrome (LS) is an autosomal dominant disorder caused by mutations in DNA mismatch repair (MMR) genes and is typically associated with colorectal, endometrial, and ovarian cancer. In this context, we describe the investigation and management of a 45-year-old female patient with a known family history of ovarian cancer and myocardial infarction who developed clinical features of hypercortisolism. Endocrine evaluation demonstrated elevated cortisol and ACTH levels. The MRI revealed a microadenoma for which the patient underwent repeat TSS and Gamma Knife radiosurgery, leading to resolution of the pituitary adenoma. Subsequently, endometrioid adenocarcinoma was diagnosed, and in view of the family history, an underlying genetic disorder was suspected and later confirmed as LS with a pathogenic MSH6 variant, representing only the second reported case of MSH6-associated pituitary adenoma. Surgical management included hysterectomy with bilateral salpingo-oophorectomy, aortopelvic lymphadenectomy, and omental biopsy. This case underscores the importance of early diagnosis and lifelong monitoring in CD to reduce mortality from uncontrolled hypercortisolism, while highlighting a possible association between LS and ACTH-secreting pituitary adenomas, particularly those with MSH6 mutations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.